Infectious Diseases and HIV Conference

The advent of antibiotics and antivirals has transformed the treatment of infectious diseases tremendously. This interferes less with morbidity and mortality counts now, although this remains a controversial issue due to antimicrobial resistance.

This session will offer an overview of these critical therapeutic agents, with a focus on mechanisms of action, challenges related to resistance, and recent innovations in treatment. Antibiotics are made specifically to hit bacterial infections and work through cell wall synthesis inhibition, inhibition of protein synthesis, and inhibition of nucleic acid synthesis.

With this in mind, participants will delve deeper into the spectrum of available antibiotics: beta-lactams, aminoglycosides, macrolides, and newer agents and their clinical applications for the treatment of different kinds of bacterial infections. Antivirals are specifically designed to treat viral infections. This session will cover how antivirals act in the course of viral replication, including entry, replication, and assembly.

A number of the important antiviral agents that are used to treat diseases such as influenza, HIV, and hepatitis will be discussed, as well as newer therapies for emerging viruses.

Despite its initial success, antibiotics and antivirals had soon brought forth the ever-increasing threat of antimicrobial resistance-a one of the most significant threats that human history has witnessed.

This session will summarize and call attention to this growing threat from overuse and misuse of these agents, and then discuss the strategies to counter the growing threat of increases. Optimal use of antibiotics with reduction of misuse will constitute stewardship programs as a significant effort. In this review, recent advances, such as combination therapy, new drugs, and phage therapy, will be presented. Emphasis will be placed on how precision medicine and personalized approaches to treatment can affect the infection management of these patients, potentially resulting in improved outcomes.

Public Health Initiatives to Promote Appropriate Use of Antibiotics and Antivirals, Improve Surveillance for Resistance, Stimulate Research and Development of New Therapeutic Options.

Join us in this fascinating session with some of the world's leading experts as we delve into the trends and intricacies of antibiotics and antivirals, with our focus on furthering your knowledge and management of infectious diseases.